Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 3 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
GSK INVESTMENT COMPANY from Hasselt, company number BE0883242111, closed financial year 2025 with a result of € 25,300 after tax. For that financial year GSK INVESTMENT COMPANY recorded a gross margin of € 221,848 and equity of € 104,925. Compared with financial year 2024, the result moved from € 318,292 to € 25,300. The company is profitable. The buffer shrank hard: equity is 89 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.
€ 104,925
▼ 89% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 25,300
▼ 92% vs 2024
Profit after tax over the fiscal year.
€ 20,836
▼ 54% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 651,425 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 5,950
▼ 45% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 1.7 million
▲ 42% vs 2024
€ 105,324 is repaid this year. At this pace the long-term loan is gone in ≈ 16 years.
€ 2,554
▲ 47% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,780
▼ 79% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 180,611 | € 234,602 | € 274,272 | € 221,848 | ▼ 19% |
| Profit after taxes | € 53,929 | € 98,975 | € 318,292 | € 25,300 | ▼ 92% |
| Equity | € 746,128 | € 721,333 | € 979,625 | € 104,925 | ▼ 89% |
| Total debts | € 2,129,078 | € 1,960,026 | € 1,707,317 | € 2,483,895 | ▲ 45% |
| Cash | € 7,578 | € 69,385 | € 45,568 | € 20,836 | ▼ 54% |
| Land & buildings | € 1,377,425 | € 1,039,572 | € 1,730,063 | € 1,656,083 | ▼ 4% |
| Retained profit | € 339,928 | € 393,133 | € 651,425 | € 25,300 | ▼ 96% |
| Dividend | € 0 | € 45,770 | € 60,000 | € 651,425 | ▲ € 591,425 |
| Bank debt | € 1,476,454 | € 1,245,636 | € 1,218,852 | € 1,735,866 | ▲ 42% |
| Balance sheet total | € 2,875,207 | € 2,681,359 | € 2,686,942 | € 2,588,820 | ▼ 4% |
Key figures of GSK INVESTMENT COMPANY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to GSK INVESTMENT COMPANY?
What happened at GSK INVESTMENT COMPANY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 25,300 (▼ 92% vs 2024). Source: NBB ↗
- New establishment in Hasselt. KBO
- Start of the company according to the CBE. KBO
In short
From € 53,929 profit in 2022 to € 25,300 profit in 2025.
Paid € 25,366 in corporate taxes since 2022.
Best year ever: 2024, with € 318,292 profit.
Paid out € 757,195 in dividends to the owners in total.
A new publication or filing at GSK INVESTMENT COMPANY? We notify you, reason included.
Follow GSK INVESTMENT COMPANYDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Group P3 comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
GSK INVESTMENT COMPANYBehind GSK INVESTMENT COMPANY is Gsk-Beheer BV. The shares are held by Group P3 (100%). It owns 100% of GSK-Beheer itself.
Directors
According to the 2025 annual accounts
Director · represented by Dries Peeters
Shareholders
100%
Participations
100%
Establishments
Establishment units
Physical locations of this company
Guffenslaan 44
3500 Hasselt
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0883.242.111
- VAT number
- BE 0883.242.111
- Registered office
- Guffenslaan 44, 3500 Hasselt
- Names & denominations
- GSK INVESTMENT COMPANY · GSK INVEST
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 31 August 2006
- Peppol
- Active · Active since 19 Jan 2026
- Activities · NACE
Groothandel in bouwmaterialen, algemeen assortiment
Groothandel in verf, vernis en bouwmaterialen, inclusief sanitair
Dakwerkzaamheden
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Detailhandel in ijzerwaren, bouwmaterialen, verf en glas (algemeen assortiment)
Technische studiën en ingenieursactiviteiten
Detailhandel in ijzerwaren, verf, bouwmaterialen (inclusief doe-het-zelfzaken) met een verkoopsoppervlakte van minder dan 400 m2
+3